Biomedical Applications of Colloidal Nanocrystals by Osinski, Marek et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2007, Article ID 82752, 2 pages
doi:10.1155/2007/82752
Editorial
Biomedical Applications of Colloidal Nanocrystals
Marek Osinski,1 Thomas M. Jovin,2 and K. Yamamoto3
1Center for High Technology Materials, University of New Mexico, 1313 Goddard SE, Albuquerque, NM 87106-4343, USA
2Department of Molecular Biology, Max Planck Institute for Biophysical Chemistry, 37070 G¨ ottingen, Germany
3Research Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan
Correspondence should be addressed to K. Yamamoto, backen@ri.imcj.go.jp
Received 6 May 2008; Accepted 6 May 2008
Copyright © 2007 MarekOsinskietal.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Becauseofthehighaﬃnityofthethiolgroupstoametalsuch
as gold and zinc, we can conjugate metal nanocrystals with
chemical compounds which contain thiol such as cysteine,
cyctein contained peptide, and thiol-modiﬁed nucleic acids
includingDNA.Amongthem,T.Pellegrinoetal.investigated
Gold-DNA conjugates in detail by a comprehensive gel-
electrophoresis study based on 1200gels. The investigation
contains the following three results: ﬁrstly, the precise detec-
tion of relative changes in size upon binding of molecules,
secondary, comparison of the speciﬁc attachment of DNA
via gold-thiol bonds to Au nanoparticles with nonspeciﬁc
adsorption of DNA, and thirdly, determination of the
maximum number of DNA molecules bounded per particle.
These data might be the essential information for designing
a functional nanodevice such as for the nanometer-sized
electric circuit and for the carrier for gene delivery system.
AnewligandwhichreadilybindsitselftoCdSe-ZnScore-
shell QDs, via surface ligand exchange, was designed and
synthesized by Kimihiro Susumu et al. from tetraethylene
glycol (TEG) based bidentate ligand functionalized with
dihydrolipoic acid (DHLA) and biotin (DHLA-TEG-biotin).
Quantum dots capped with DHLA and DHLA-TEG-biotin
or polyethylene glycol modiﬁed DHLA (DHLA-PEG600) are
dispersed easily in aqueous buﬀer solutions. Homogenized
buﬀer solutions of QDs capped with mixture of DHLA-
PEG600 and DHLA-TEG-biotin are stable over broad pH
range and showed speciﬁc interactions with NeutrAvidin in
surface binding assays. The authors say “further studies of
these surface functionalized QDs for coupling with a variety
of bioreceptors and biological assays are in progress.”
For the study on the ligand-receptor binding, we need
ﬂuorescent markers. Ligand conjugated quantum dots are
reported here by Ian D. Tomlinson et al. for imaging GABAc
receptor on the surface membrane of intact cell. They
have already succeeded in developing serotonin-conjugated
quantum dots and the method to reduce nonspeciﬁc binding
using PEGylated quantum dots. Together with all these
works, they have proceeded for imaging GABAc receptors
heterologously expressed on Xenopus laevis oocytes.
On the other hand, Dopamine conjugated quantum dots
are known to be endocytozed by cells bearing dopamine
receptors and not by cells without dopamine receptors.
RafaelKhatchadourianetal.studiedthetoolsofﬂuorescence
intensity and intermittency for following dopamine biocon-
jugate processing in living cells.
In this special issue, we have three papers on quantum
dots as for the use of Forster (or ﬂuorescent) resonance
energy transfer (FRET). The characters of quantum dots
suchasphotostability,highquantumyieldbroadabsorption,
and narrow emission spectrum are more useful for probes
than organic dyes, especially in the study of molecular
imaging.
In the investigation of E. Z. Chong et al., biotinylated
DY731-Bio ﬂuorophores with an absorption peak at 720nm
were self-assembled onto Qdot705-STVs that emit the
ﬂuorophores at 705nm using a streptavidin-biotin binding
mechanism. They have particular interest on the far-red
region to minimize optical region absorption within tissue
and to avoid cell autoﬂuorescence and they succeeded in
doing so.
In order to identify selective inhibitors of protein kinases
eﬃciently, Ibrahim Yildiz et al. designed a binding assay
to probe the interactions of human phosphoinositide-
dependent protein kinase-1 with potential ligands using
FRET between quantum dots and organic dyes.
Using terbium complexes as donors and quantum dots
as acceptors, FRET immunoassay is improved more than
two orders of magnitude compared to commercial systems,2 Journal of Biomedicine and Biotechnology
which has been investigated by Niko Hildebrandt et al. They
say “the presented results demonstrate the great potential
of Tb to QD-FRET system for highly sensitive homogenous
immunoassays for biological as well as clinical and medical
applications.”
For the application of MRI imaging, the following
two papers are included. Mi Kyong Yoo et al. developed
superparamagnetic iron oxide nanoparticles (SPIONs). SPI-
ONs were coated with agent (PVLA-coated SPIONs) to be
recognized by asialoglycoprotein receptors on hepatocytes.
Intracellular uptake of this nanoparticle was visualized by
confocal laser scanning microscopy and the hepatocyte-
speciﬁc delivery was also investigated with magnetic res-
onance image of rat liver. The authors said “the results
suggest the potential utility of PVLA-coated SPIONs as liver-
targeting MRI contrast agent.”
Quantum dots are absolutely useful for clinical labo-
ratory test. Dilan Qin et al. say “tuberculosis is a global
health threatening emergency with the spread of acquired
immunodeﬁciency syndrome and the emergence of a drug-
resistant strain of mycobacterium tuberculosis.” They used
RuBpy-doped silica nanoparticles as the ﬂuorescent probe
to detect the bacteria with an indirect immunoﬂuorescence
microscopy.Four-hourassaytimeisenoughincludingspiked
sputum sample pretreatment, which can be done by the
advantage of higher luminescence and higher photostability
for the nanoparticles.
For the study on the clinical treatment, we have a paper
of Magdalena M. Stevanovi´ c et al. They produced copolymer
poly(D,L-lactide-co-glycolide) (DLPLG) nanoparticles by
using physical method with solvent/nonsolvent systems and
technique of the centrifugal processing. Encapsulation of
ascorbic acids into DLPLG particles can be used for trans-
dermal controlled delivery of ascorbic acids. The authors say
“DLPLGnanospheresareveryeﬃcientmeansoftransdermal
transport of medicament within the polymer matrix.”
Finally, this special issue includes two review articles.
One is from Arthur M. Iga et al. They describe the clinical
potential of quantum dots focused in sentinel lymph node
mapping, cancer imaging, photodynamic therapy in cancer
treatment, and drug delivery. The authors examined the
hindrances for clinical use and the current progress in
abrogating their inherent toxicity. The other review is from
Camilla Luccardini et al. They start from the chemical and
optical properties of nanocrystals and surface chemistry.
They cross the description of plasma membrane section and
reach the speciﬁc intracellular targets. They also describe
a whole animal imaging in vivo with nanocrystals and
cytotoxity of cadmium ion as an example.
Both of the authors of the review articles have taken the
topics of toxicity commonly. Silica coating of the quantum
dots might be one of the ways to escape from the cytotoxity.
Masanori Ando et al. say “here we report the preparation
of silica particle phosphor incorporating ZnSe-based NCs
prepared by a reverse micelle method.” The size distribution
of the spherical particles is 20–40nm in diameter. They have
already reported the presentation of green- and red-emitting
silicaparticles.“Theseemittingsilicaparticlesareexpectedto
be applicable as ﬂuorescent biomarkers,” they also say. Their
method of silica coating might be applicable for any type of
the nanoparticles.
On the other hand, Arthur M. Iga et al. say “with im-
provements in nanotechnology, nanotoxicology, and chem-
istry some of the goals could be achieved, however, it will be
diﬃcult to replace the toxic core of the QD without losing
optical properties or we will redirect our eﬀorts to less toxic
elements.” All of us might have to think about it deeply.
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